A new physiological medium uncovers biochemical and cellular alterations in Lesch-Nyhan disease fibroblasts

被引:2
作者
Escudero-Ferruz, Paula [1 ,2 ]
Ontiveros, Neus [1 ,2 ]
Cano-Estrada, Claudia [1 ,2 ]
Sutcliffe, Diane J. [3 ]
Jinnah, H. A. [3 ,4 ,5 ]
Torres, Rosa J. [6 ,7 ]
Lopez, Jose M. [1 ,2 ]
机构
[1] Univ Autonoma Barcelona, Inst Neurociencies, Cerdanyola Del Valles 08193, Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Unitat Bioquim, Fac Med, Cerdanyola Del Valles 08193, Barcelona, Spain
[3] Emory Univ, Dept Neurol, Sch Med, 101 Woodruff Circle,6305 Woodruff Mem Bldg, Atlanta, GA 30322 USA
[4] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA
[5] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA 30322 USA
[6] Inst Salud Carlos III ISCIII, Ctr Biomed Network Res Rare Dis, Madrid 28029, Spain
[7] La Paz Univ Hosp Hlth Res Inst, Dept Biochem, IdiPaz, Madrid 28046, Spain
关键词
Purine nucleotides; Folic acid; Lesch-Nyhan disease; ZMP; AICAR; Plasmax; ACTIVATED PROTEIN-KINASE; 5-AMINO-4-IMIDAZOLECARBOXAMIDE RIBOSIDE; METABOLISM; BIOSYNTHESIS;
D O I
10.1186/s10020-023-00774-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundLesch-Nyhan disease (LND) is a severe neurological disorder caused by the genetic deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGprt), an enzyme involved in the salvage synthesis of purines. To compensate this deficiency, there is an acceleration of the de novo purine biosynthetic pathway. Most studies have failed to find any consistent abnormalities of purine nucleotides in cultured cells obtained from the patients. Recently, it has been shown that 5-aminoimidazole-4-carboxamide riboside 5MODIFIER LETTER PRIME-monophosphate (ZMP), an intermediate of the de novo pathway, accumulates in LND fibroblasts maintained with RPMI containing physiological levels (25 nM) of folic acid (FA), which strongly differs from FA levels of regular cell culture media (2200 nM). However, RPMI and other standard media contain non-physiological levels of many nutrients, having a great impact in cell metabolism that does not precisely recapitulate the in vivo behavior of cells.MethodsWe prepared a new culture medium containing physiological levels of all nutrients, including vitamins (Plasmax-PV), to study the potential alterations of LND fibroblasts that may have been masked by the usage of non-physiological media. We quantified ZMP accumulation under different culture conditions and evaluated the activity of two known ZMP-target proteins (AMPK and ADSL), the mRNA expression of the folate carrier SLC19A1, possible mitochondrial alterations and functional consequences in LND fibroblasts.ResultsLND fibroblasts maintained with Plasmax-PV show metabolic adaptations such a higher glycolytic capacity, increased expression of the folate carrier SCL19A1, and functional alterations such a decreased mitochondrial potential and reduced cell migration compared to controls. These alterations can be reverted with high levels of folic acid, suggesting that folic acid supplements might be a potential treatment for LND.ConclusionsA complete physiological cell culture medium reveals new alterations in Lesch-Nyhan disease. This work emphasizes the importance of using physiological cell culture conditions when studying a metabolic disorder.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Update on the Phenotypic Spectrum of Lesch-Nyhan Disease and its Attenuated Variants
    Rosa J. Torres
    Juan G. Puig
    H. A. Jinnah
    Current Rheumatology Reports, 2012, 14 : 189 - 194
  • [32] Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder
    Fu, Rong
    Ceballos-Picot, Irene
    Torres, Rosa J.
    Larovere, Laura E.
    Yamada, Yasukazu
    Nguyen, Khue V.
    Hegde, Madhuri
    Visser, Jasper E.
    Schretlen, David J.
    Nyhan, William L.
    Puig, Juan G.
    O'Neill, Patrick J.
    Jinnah, H. A.
    BRAIN, 2014, 137 : 1282 - 1303
  • [33] Quantification of various APP-mRNA isoforms and epistasis in Lesch-Nyhan disease
    Khue Vu Nguyen
    Nyhan, William L.
    NEUROSCIENCE LETTERS, 2017, 643 : 52 - 58
  • [34] Brain white matter volume abnormalities in Lesch-Nyhan disease and its variants
    Schretlen, David J.
    Varvaris, Mark
    Vannorsdall, Tracy D.
    Gordon, Barry
    Harris, James C.
    Jinnah, H. A.
    NEUROLOGY, 2015, 84 (02) : 190 - 196
  • [35] A Trivalent Enzymatic System for Uricolytic Therapy of HPRT Deficiency and Lesch-Nyhan Disease
    Ronda, Luca
    Marchetti, Marialaura
    Piano, Riccardo
    Liuzzi, Anastasia
    Corsini, Romina
    Percudani, Riccardo
    Bettati, Stefano
    PHARMACEUTICAL RESEARCH, 2017, 34 (07) : 1477 - 1490
  • [36] Novel mutation in the human HPRT1 gene and the Lesch-Nyhan disease
    Khue Vu Nguyen
    Naviaux, Robert K.
    Nyhan, William L.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2017, 36 (11) : 704 - 711
  • [37] A Trivalent Enzymatic System for Uricolytic Therapy of HPRT Deficiency and Lesch-Nyhan Disease
    Luca Ronda
    Marialaura Marchetti
    Riccardo Piano
    Anastasia Liuzzi
    Romina Corsini
    Riccardo Percudani
    Stefano Bettati
    Pharmaceutical Research, 2017, 34 : 1477 - 1490
  • [38] Study of the adenosinergic system in the brain of HPRT knockout mouse (Lesch-Nyhan disease)
    Bertelli, Matteo
    Cecchin, Stefano
    Lapucci, Cristina
    Jacomelli, Gabriella
    Jinnah, Hyder A.
    Pandolfo, Massimo
    Micheli, Vanna
    CLINICA CHIMICA ACTA, 2006, 373 (1-2) : 104 - 107
  • [39] Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease
    Visser, JE
    Smith, DW
    Moy, SS
    Breese, GR
    Friedmann, T
    Rothstein, JD
    Jinnah, HA
    DEVELOPMENTAL BRAIN RESEARCH, 2002, 133 (02): : 127 - 139
  • [40] Molecular Characterization and Structure Analysis of Hprt in a Chinese Patient with Lesch-Nyhan Disease
    Jian, Wei-Xia
    Peng, Wen-Hui
    Li, Hai-Ling
    Feng, Qi-Wen
    Wang, Wei-Xing
    Su, Qing
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2013, 32 (04) : 189 - 195